Clinical Trial Details
EORTC-62063
Back to Clinical Trials Database
A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 20-May-2009 Date Step1 close: 11-Mar-2011 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 280 - All Groups: 350 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00956072 |
| NCT number | NCT00956072 |
| EudraCT | 2007-002257-23 |
